![](/img/cover-not-exists.png)
FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancer
Lim, Bora, Scicchitano, Angelique, Beachler, Cheryl, Gusani, Niraj, Sarwani, Nabeel, Yang, Zhaohai, Staveley-O’Carroll, Kevin, Ashkenazi, Avi, Portera, Chia, El-Deiry, Wafik SVolume:
14
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/cbt.25310
Date:
August, 2013
File:
PDF, 1.65 MB
english, 2013